Brean Capital said Manhattan Associates has expanded its total addressable market opportunity while continuing to expand its product footprint. The firm believes the shares currently reflect the company's consistency, but can see its multiple expand and its valuation rise as the company continues to show solid, consistent execution. Brean Capital reiterated its Buy rating and $75 price target on Manhattan Associates shares.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSAudioEye (AEYE) up... To see the rest of the story go to thefly.com. See Story Here